AlphaCentric Advisors’s Globus Medical GMED Stock Holding History

AlphaCentric Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$790K	Buy	10,000 +2,500	+33%	+$212K	0.67%	40
2026 Q1	$646K	Sell	7,500 -1,212	-14%	-$109K	0.65%	43
2025 Q4	$761K	Buy	+8,712	New	+$661K	0.76%	35
2024 Q4	$2M	Buy	+24,176	New	+$1.91M	2%	10
2024 Q2	–	Sell	-12,500	Closed	-$671K	–	235
2024 Q1	$671K	Buy	+12,500	New	+$672K	0.4%	77
2023 Q4	–	Sell	-10,000	Closed	-$497K	–	253
2023 Q3	$497K	Buy	+10,000	New	+$559K	0.28%	88
2023 Q1	–	Sell	-10,000	Closed	-$743K	–	214
2022 Q4	$743K	Buy	10,000 +9,000	+900%	+$613K	0.73%	49
2022 Q3	$60K	Buy	+1,000	New	+$60.2K	0.06%	169
2021 Q1	–	Sell	-15,000	Closed	-$978K	–	213
2020 Q4	$978K	Hold	15,000	–	–	0.41%	17
2020 Q3	$743K	Hold	15,000	–	–	0.36%	22
2020 Q2	$716K	Buy	+15,000	New	+$724K	0.4%	21

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

AlphaCentric Advisors's GMED Position: Q2 2026 in Review

AlphaCentric Advisors increased its Globus Medical (GMED) stake by 33% in Q2 2026, buying an estimated $212K and bringing the position to 10,000 shares worth $790K. The position accounts for 0.67% of the portfolio, ranked #40.

AlphaCentric Advisors first reported a position in GMED in Q2 2020 and has held it in 11 quarters since. The position peaked at $2M in Q4 2024. 599 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

AlphaCentric Advisors held 10,000 shares of Globus Medical worth $790K as of Q2 2026.
AlphaCentric Advisors bought 2,500 Globus Medical shares in Q2 2026, an estimated $212K.
Globus Medical made up 0.67% of AlphaCentric Advisors's portfolio in Q2 2026, its #40 holding.
AlphaCentric Advisors first reported a position in Globus Medical in Q2 2020 and has held it in 11 quarters since.
AlphaCentric Advisors's Globus Medical position peaked at $2M in Q4 2024.
599 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on AlphaCentric Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.